NCT03313414View on ClinicalTrials.gov

HCV Post-Exposure Prophylaxis for Health Care Workers

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 13, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

January 16, 2020

Conditions
Hepatitis C
Interventions
DRUG

Sofosbuvir/Velpatasvir Treatment for 14 days

14 day therapy with Sofosbuvir/Velpatasvir

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Massachusetts General Hospital

OTHER